India
# |
Name |
Price to Book Ratio (P/B) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
20.51 |
Feb. 7, 2025 | USD 25.14 | -2.56% |
|
India |
|
2 |
7.58 |
Feb. 7, 2025 | USD 18.21 | -3.37% |
|
India |
|
3 |
6.90 |
Feb. 7, 2025 | USD 11.74 | -1.33% |
|
India |
|
4 |
5.29 |
Feb. 7, 2025 | USD 21.37 | -1.96% |
|
India |
|
5 |
5.26 |
Feb. 7, 2025 | USD 17.54 | 2.44% |
|
India |
|
6 |
2.96 |
Feb. 7, 2025 | USD 4.72 | -3.66% |
|
India |
|
7 |
2.20 |
Feb. 7, 2025 | USD 13.57 | -0.25% |
|
India |
The Vaccines company in India with the highest Price to Book Ratio (P/B) is GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO.NS) at 20.51.
The Vaccines company in India with the lowest Price to Book Ratio (P/B) is Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) at 2.20.
The top 10 Vaccines companies in India by Price to Book Ratio (P/B) are GlaxoSmithKline Pharmaceuticals Limited, Wockhardt Limited, Vimta Labs Limited, Hester Biosciences Limited, Glenmark Pharmaceuticals Limited, Panacea Biotec Limited and Aurobindo Pharma Limited.
The bottom 10 Vaccines companies in India by Price to Book Ratio (P/B) are Aurobindo Pharma Limited, Panacea Biotec Limited, Glenmark Pharmaceuticals Limited, Hester Biosciences Limited, Vimta Labs Limited, Wockhardt Limited and GlaxoSmithKline Pharmaceuticals Limited.